<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03246191</url>
  </required_header>
  <id_info>
    <org_study_id>2015BAI12B06－2</org_study_id>
    <nct_id>NCT03246191</nct_id>
  </id_info>
  <brief_title>Screening and Assessing the Risk Factors and Complications of Chronic Kidney Disease</brief_title>
  <official_title>Screening and Assessing the Risk Factors and Complications of Chronic Kidney Disease：a Cross - Sectional Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Chinese PLA General Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Chinese PLA General Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study is an observational, cross-sectional study aimed at screening and accessing risk
      factors and complications for Chinese chronic kidney disease (CKD) patients. To investigate
      the prevalence of hypertension, cardiovascular and cerebrovascular diseases, protein energy
      malnutrition（PEM）, cognitive impairment and other complications in the CKD patients. To
      develop biomarkers of CKD.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">August 2017</start_date>
  <completion_date type="Anticipated">May 2018</completion_date>
  <primary_completion_date type="Anticipated">May 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Prevalence of CKD complications</measure>
    <time_frame>baseline</time_frame>
    <description>hypertension, cardiovascular and cerebrovascular diseases, protein energy malnutrition(PEM), cognitive impairment</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Biomarkers of kidney function</measure>
    <time_frame>baseline</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Genetic analyses</measure>
    <time_frame>baseline</time_frame>
    <description>circulating microRNA</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Questionnaire assessing cognitive function</measure>
    <time_frame>baseline</time_frame>
    <description>Montreal Cognitive Assessment-Basic Chinese Version</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Questionnaire assessing depression</measure>
    <time_frame>baseline</time_frame>
    <description>Beck Depression Inventory scores</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Questionnaire assessing risk of malnutrition</measure>
    <time_frame>baseline</time_frame>
    <description>Malnutrition-Inflammation Score</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Questionnaire assessing dietary intake</measure>
    <time_frame>baseline</time_frame>
    <description>Food Frequency Questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Questionnaire assessing quality of life</measure>
    <time_frame>baseline</time_frame>
    <description>Activity of daily living（ADL）and kidney disease quality of life （KDQOLTM-36）</description>
  </secondary_outcome>
  <enrollment type="Anticipated">900</enrollment>
  <condition>Chronic Kidney Disease</condition>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>blood sample collection</intervention_name>
    <description>blood sample collection</description>
  </intervention>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      serum, whole blood，urine
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        subjects with 18 years or older
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  age≥18 years

          -  clinical diagnosis of CKD

          -  signed informed consent

        Exclusion Criteria:

          -  End-stage renal disease(ESRD) or dialysis

          -  Acute kidney injure(AKI)

          -  history of solid organ or bone marrow transplantation

          -  active malignancy within 24 months prior to screening or metastatic cancer

          -  HIV infection or AIDS

          -  acute inflammation
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>xiangmei chen</last_name>
    <role>Principal Investigator</role>
    <affiliation>Chinese PLA General Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>guangyan cai</last_name>
    <phone>00861066935462</phone>
    <email>caiguangyan@sina.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>wenling wang</last_name>
    <phone>008618600258258</phone>
    <email>wangwenlingczyy@163.com</email>
  </overall_contact_backup>
  <verification_date>August 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 13, 2017</study_first_submitted>
  <study_first_submitted_qc>August 8, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">August 11, 2017</study_first_posted>
  <last_update_submitted>August 8, 2017</last_update_submitted>
  <last_update_submitted_qc>August 8, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">August 11, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Chinese PLA General Hospital</investigator_affiliation>
    <investigator_full_name>Chen Xiangmei</investigator_full_name>
    <investigator_title>Academician of Chinese Academy of Engineering</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Kidney Diseases</mesh_term>
    <mesh_term>Renal Insufficiency, Chronic</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

